Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms

Publication date: July 2017 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 17, Supplement Author(s): Umang Patel, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Keyur P. Patel The classification and risk stratification of myeloid neoplasms, including acute myeloid leukemia, myelodysplastic syndromes, myelodysplastic syndromes/myeloproliferative neoplasms, and myeloproliferative neoplasms, have increasingly been guided by molecular genetic abnormalities. Gene expression analysis and next-generation sequencing have led to the ever increasing discovery of somatic gene mutations in myeloid neoplasms. Mutations have been identified in genes involved in epigenetic modification, RNA splicing, transcription factors, DNA repair, and the cohesin complex. These new somatic/acquired gene mutations have refined the classification of myeloid neoplasms and have been incorporated into the 2016 update of the World Health Organization (WHO) classification and the National Comprehensive Cancer Network guidelines. They have also been helpful in the development of new targeted therapeutic agents. In the present review, we describe the clinical utility of recently identified, clinically important gene mutations in myeloid neoplasms, including those incorporated in the 2016 update of the WHO classification.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research

Related Links:

Publication date: August–September 2018Source: Medicina Intensiva (English Edition), Volume 42, Issue 6Author(s): F.D. Martos-Benítez, A. Gutiérrez-Noyola, M. Badal, N.A. DietrichAbstractObjectivesTo determine the risk factors for severe acute respiratory failure requiring invasive mechanical ventilation (SARF-MV) and its effect upon clinical outcomes in critically ill cancer patients.DesignA retrospective cohort study was carried out.SettingA 12-bed oncological intensive care unit (ICU) from January 2014 to December 2015.PatientsA total of 878 consecutive cancer patients were included. Patients with an...
Source: Medicina Intensiva - Category: Intensive Care Source Type: research
Publication date: August–September 2018Source: Medicina Intensiva (English Edition), Volume 42, Issue 6Author(s): A. Carmona-Bayonas, F. Gordo, C. Beato, J. Castaño Pérez, P. Jiménez-Fonseca, J. Virizuela Echaburu, J. Garnacho-MonteroAbstractCancer patients are a vulnerable group exposed to numerous and serious risks beyond cancer itself. In recent years, the prognosis of these individuals has improved substantially thanks to several advances such as immunotherapy, targeted molecular therapies, surgical techniques, or developments in support treatment. This coincides with the prolonged survival o...
Source: Medicina Intensiva - Category: Intensive Care Source Type: research
SKIN cancer symptoms are triggered when skin cells start to divide uncontrollably. There are two main types of skin cancer, called melanoma and non-melanoma skin cancer. Watch out for this major warning sign of skin cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Emma Neagu, now 14, from Toronto, was diagnosed with a form of bone cancer known as osteosarcoma in 2016. The teen endured nine months of grueling chemotherapy.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This article focused on the CML and epigenetic and clinical significance. An electronic search of peer-reviewed articles was systematically performed to obtain the relevant literature with the CINAHL, cancer, Google scholar, self-experience and PubMed databases. The keywords included leukemia, cancer, illness, epigenetic. The inclusion criteria for the reviews were that the documents were original quantitative research and published in English. Articles that were not directly relevant to the present objective were excluded. Current progress in molecular biology and bioinformatics offer novel promising experiments namely as...
Source: Cellular and Molecular Biology - Category: Molecular Biology Tags: Cell Mol Biol (Noisy-le-grand) Source Type: research
Authors: Steckiewicz KP, Barcińska E, Woźniak M Abstract Nerve growth factor (NGF) is protein discovered by Rita Levi Montalcini in the 1950s. It plays a crucial role in the development of nervous system. NGF may be produced by a variety of cells even beyond nervous system. NGF modulate cell metabolism by binding to p75NTR and TrkA receptors. NGF is involved in psychological processes and may be the possible therapeutical agent for diabetes, cancer and cardiovascular diseases, which will be described in the article. PMID: 30030957 [PubMed - in process]
Source: Cellular and Molecular Biology - Category: Molecular Biology Tags: Cell Mol Biol (Noisy-le-grand) Source Type: research
BOWEL cancer symptoms occur when cells start to divide uncontrollably in the large intestine. Signs and symptoms can be observed in the toilet bowl, or through how someone is feeling. Watch out for these warning signs of colon cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Obesity, Type 2 diabetes and metabolic syndrome, all of which have risen to epidemic levels in recent years, are linked to pancreatic cancer.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Pancreatic Cancer Smoking and Tobacco Pancreas Diabetes Source Type: news
In July 2014, Phil Rech, then 59, was diagnosed with tonsil cancer.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Wenwen Zhang, Mengmeng Jiang, Jieying Chen, Rui Zhang, Yingnan Ye, Pengpeng Liu, Wenwen Yu, Jinpu Yu
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | International Medicine & Public Health | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Myeloproliferative Disorders | WHO